# Bioequivalence Study of SB797620 in Healthy Japanese Volunteers

> **NCT00549263** · PHASE1 · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** SB797620

## Key facts

- **NCT ID:** NCT00549263
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No subjects enrolled, bio equivalence study, canceled before active.
- **Last updated:** 2015-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00549263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00549263, "Bioequivalence Study of SB797620 in Healthy Japanese Volunteers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00549263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*